Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acacia Research Corporation
Acacia Research Reports Third Quarter 2009 Financial Results
November 4th, 2009
Acacia Research Corporation (Nasdaq: ACTG) reported results for the three months ended September 30, 2009. "Acacia Research generated $16,831,000 in licensing transactions in the third quarter of 2009, resulting in third quarter license fee revenues of $12,831,000, a decrease of 7%, compared to $13,796,000 in the year ago period, and deferred revenues of $4,000,000 which will be recognized as revenues in subsequent periods," commented Acacia Research Chairman and CEO, Paul Ryan. "Acacia Research trailing 12-month revenues were $58,779,000, an increase of 40%, compared to $41,963,000 at the end of the third quarter of 2008." ...
Source: Medical Patent Law Weekly (2009-11-04)
|